CAS 147025-53-4
:Talsaclidine
Description:
Talsaclidine is a chemical compound that belongs to the class of muscarinic receptor antagonists, primarily investigated for its potential therapeutic applications in treating cognitive disorders, particularly Alzheimer's disease. It is characterized by its ability to selectively inhibit certain subtypes of muscarinic acetylcholine receptors, which play a crucial role in neurotransmission and cognitive function. The compound is known for its favorable pharmacokinetic properties, including good oral bioavailability and a manageable half-life, which contribute to its potential efficacy in clinical settings. Talsaclidine's chemical structure features specific functional groups that enhance its binding affinity to target receptors while minimizing off-target effects. Research has indicated that it may improve cognitive performance and memory retention in preclinical models, although further studies are necessary to fully understand its safety profile and therapeutic potential in humans. As with many investigational drugs, ongoing clinical trials will provide more insights into its effectiveness and possible side effects.
Formula:C10H15NO
InChI:InChI=1/C10H15NO/c1-2-7-12-10-8-11-5-3-9(10)4-6-11/h1,9-10H,3-8H2/t10-/m0/s1
InChI key:InChIKey=XVFJONKUSLSKSW-JTQLQIEISA-N
SMILES:O(CC#C)[C@@H]1[C@@]2(CCN(C1)CC2)[H]
Synonyms:- (3R)-3-(2-Propyn-1-yloxy)-1-azabicyclo[2.2.2]octane
- (3R)-3-(prop-2-yn-1-yloxy)-1-azabicyclo[2.2.2]octane
- (R)-3-(2-Propynyloxy)-1-Azabicyclo[2.2.2]octane, WAL 2014
- (R)-3-(2-Propynyloxy)-1-azabicyclo[2.2.2]octane
- 1-Azabicyclo[2.2.2]octane, 3-(2-propyn-1-yloxy)-, (3R)-
- 1-Azabicyclo[2.2.2]octane, 3-(2-propynyloxy)-, (R)-
- Talsaclidine
- WAL 2014
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
1-Azabicyclo[2.2.2]octane, 3-(2-propyn-1-yloxy)-, (3R)-
CAS:Formula:C10H15NOPurity:97.0%Color and Shape:LiquidMolecular weight:165.2322Talsaclidine Hydrochloride
CAS:Controlled Product<p>Applications Talsaclidine, a novel M1-receptor selective muscarinic agonist for cholinergic substitution therapy of Alzheimer's disease. Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of A beta 42 in patients with Alzheimer's disease.<br>References Hock, et al.: Amyloid, 10(1), 1 (2003), Moreau, M., et al.: J. Pharmacol. Sci., 99, 6 (2005),<br></p>Formula:C10H16ClNOColor and Shape:NeatMolecular weight:201.69Talsaclidine
CAS:Talsaclidine: full M1 agonist, partial M2/M3 agonist with neuron-stimulating effects.Formula:C10H15NOPurity:98%Color and Shape:SolidMolecular weight:165.23



